PROST
Laufzeit: 01.01.2024 - 31.12.2025
imported
Kurzfassung
A trial of prednisolone in combination with SPI-62 or placebo in
participants with polymyalgia rheumatica (PMR).
Laufzeit: 01.01.2024 - 31.12.2025
A trial of prednisolone in combination with SPI-62 or placebo in
participants with polymyalgia rheumatica (PMR).